Coherus BioSciences' Series A Round

Coherus BioSciences raised a round of funding on March 10, 2011. Investors include MX II Associates.

Coherus is a biologics platform company focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medications worldwide. Headquartered in the San Fran…

Articles about Coherus BioSciences' Series A Round: